Biopharmaceutical production depends on buffers. Making sure the right buffer solutions are available, in the right place on the manufacturing line, at the right time, and in the right quantity, is a ...
The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...
Discover valuable insights for transforming your biopharmaceutical production with our comprehensive resource. We take a deep dive into the latest industry trend of outsourcing buffer and process ...
We listened to our customers’ frustrations with the complex process of centralized GMP liquid media manufacturing. With the Krakatoa® K500, we begin a journey to co-locate both media and buffer ...
PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Aceto, a leading global provider of specialty materials for life sciences and advanced technology end markets, announced today its acquisition of A&C Bio Buffer ...
Nucleus Biologics launched the Krakatoa ® K500, which the company says is the first bioreactor-scale, pod-based media and buffer manufacturing system designed to deliver sterile solutions on demand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results